re Jon's Post:
"Hi, I have done some research on SF1019 for a relative and I believe that it is plainly a scam of some sorts. If you visit the Daval International web site there is a link in the news section to a law suit brought by Daval against The Argyll Group. This is the group Osmond is involved with and is made up of ex Directors and ex scientific people from Daval. Not so long ago Osmond was singing the praises of Daval's drug, now he is saying the same things about SF1019. I think he is just in it for the money and have advised my relative to stay clear of this group. I have tried to gain more infomation from the SF1019 website but have drawn a blank. Osmond is now saying (Osmondms.com) the serum is registered as a Public company (IMMUNOSYN) and will be listed on NASDAQ within the next 30-45 days. This just sounds like a money making exercise to me I am afraid."
You make an interesting point about the former Daval scientists which makes you wonder why such prominent and extremely well respected scientists left them in the first place.
If you search the British, European and US patent offices you will find that neither Daval or Aimsco Ltd, who are the supposed patent owners have any granted patents.
Only patent applications are filed for AIMSPRO which means zip, so why are they are taking people to court. It might be something more to do with Daval's Chairman, David Shotton and his wife, who before the "High Court" action was started by Daval, were already being sued in the same court where it is alleged that the Shottons misappropriated $3 million plus from an alleged investor who is now amazingly one of the Daval defendants. Don't forget that David Shotton and his wife are according to the Sunday Times Article dischaged Bankrupts. http://www.timesonline.co.uk/article/0, ... 72158.html
If any here is a lawyer, they might take the trouble to read the court filings, which in the case of the Daval action are long on accusations and lacking in detail
The specials license for Aimspro is not designed for large scale manufacture or patient use and does not in itself give any guarantee of safety or efficaccy, in fact these matters are not even considered since the intent of the license is to allow Doctors to make up specials for individual patients.
A full clinical trial is needed to establish safety and efficaccy etc and it is worthy of note that Daval have been promising to start new clinical trials after the others were stopped for the past two years.
I suggest that there is much more going on here than meets the eye and also wonder, if in your research, you found this link http://argyllbiotechnologies-uk.co.uk/
which suggests that Argyll onward licenses its finished products and gives a rough outline of its' plans.
I think that Davals' comments on their website about the MS society speaks reams as does this link http://www.mssociety.org.uk/news_events ... times.html
In closing patients matter and not this battle between companies, although I must say that Argyll unlike Daval, do not denigrate anybody.
I will keep digging and post more in the future.